GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Cash Ratio

Medlive Technology Co (HKSE:02192) Cash Ratio : 23.19 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Medlive Technology Co's Cash Ratio for the quarter that ended in Dec. 2023 was 23.19.

Medlive Technology Co has a Cash Ratio of 23.19. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Medlive Technology Co's Cash Ratio or its related term are showing as below:

HKSE:02192' s Cash Ratio Range Over the Past 10 Years
Min: 0.54   Med: 12.75   Max: 34.53
Current: 23.19

During the past 6 years, Medlive Technology Co's highest Cash Ratio was 34.53. The lowest was 0.54. And the median was 12.75.

HKSE:02192's Cash Ratio is ranked better than
98.95% of 95 companies
in the Medical Distribution industry
Industry Median: 0.23 vs HKSE:02192: 23.19

Medlive Technology Co Cash Ratio Historical Data

The historical data trend for Medlive Technology Co's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Cash Ratio Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial 0.86 2.30 34.53 31.77 23.19

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.53 34.01 31.77 20.45 23.19

Competitive Comparison of Medlive Technology Co's Cash Ratio

For the Medical Distribution subindustry, Medlive Technology Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's Cash Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Cash Ratio falls into.



Medlive Technology Co Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Medlive Technology Co's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=4813.606/207.569
=23.19

Medlive Technology Co's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=4813.606/207.569
=23.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medlive Technology Co  (HKSE:02192) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Medlive Technology Co Cash Ratio Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines